Fulton Bank, N.A. Regeneron Pharmaceuticals, Inc. Transaction History

Fulton Bank, N.A.

$1.26 Billion
Q2 2025

A detailed history of Fulton Bank, N.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 2,578 shares of REGN stock, worth $1.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,578

Previous 2,807 8.16%

Holding current value

$1.5 Million

Previous $1.78 Million 23.99%

% of portfolio

0.11%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	SELL	$483.07 - $625.6 $110,623 - $143,262	-229 Reduced 8.16%	2,578 $1.35 Million
Q1 2025 Apr 09, 2025	SELL	$634.14 - $744.83 $163,608 - $192,166	-258 Reduced 8.42%	2,807 $1.78 Million
Q4 2024 Jan 08, 2025	SELL	$701.85 - $1046.91 $215,467 - $321,401	-307 Reduced 9.1%	3,065 $2.18 Million
Q3 2024 Oct 07, 2024	SELL	$1024.09 - $1201.76 $563,249 - $660,968	-550 Reduced 14.02%	3,372 $3.54 Million
Q2 2024 Jul 09, 2024	BUY	$883.2 - $1071.19 $51,225 - $62,129	58 Added 1.5%	3,922 $4.12 Million
Q1 2024 Apr 10, 2024	BUY	$902.69 - $993.35 $100,198 - $110,261	111 Added 2.96%	3,864 $3.72 Million
Q4 2023 Jan 04, 2024	SELL	$775.18 - $881.7 $158,911 - $180,748	-205 Reduced 5.18%	3,753 $3.3 Million
Q3 2023 Oct 04, 2023	BUY	$692.45 - $844.37 $65,782 - $80,215	95 Added 2.46%	3,958 $3.26 Million
Q2 2023 Jul 06, 2023	SELL	$700.03 - $830.35 $275,111 - $326,327	-393 Reduced 9.23%	3,863 $2.78 Million
Q1 2023 Apr 06, 2023	BUY	$680.49 - $826.97 $172,163 - $209,223	253 Added 6.32%	4,256 $3.5 Million
Q4 2022 Jan 05, 2023	BUY	$705.89 - $766.39 $224,473 - $243,712	318 Added 8.63%	4,003 $2.89 Million
Q3 2022 Oct 04, 2022	BUY	$573.97 - $724.32 $297,316 - $375,197	518 Added 16.36%	3,685 $2.54 Million
Q2 2022 Jul 07, 2022	BUY	$548.35 - $738.84 $14,257 - $19,209	26 Added 0.83%	3,167 $1.87 Million
Q1 2022 Apr 05, 2022	BUY	$595.12 - $698.43 $57,131 - $67,049	96 Added 3.15%	3,141 $2.19 Million
Q4 2021 Jan 05, 2022	BUY	$543.48 - $670.97 $150,543 - $185,858	277 Added 10.01%	3,045 $1.92 Million
Q3 2021 Oct 05, 2021	BUY	$574.03 - $680.96 $47,070 - $55,838	82 Added 3.05%	2,768 $1.68 Million
Q2 2021 Jul 06, 2021	BUY	$472.8 - $558.54 $1.27 Million - $1.5 Million	2,686 New	2,686 $1.5 Million

Others Institutions Holding REGN

# of Institutions

1,420

Shares Held

88.7M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $62.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account